Pro Share Advisors LLC Ab Cellera Biologics Inc. Transaction History
Pro Share Advisors LLC
- $48.7 Billion
- Q2 2025
A detailed history of Pro Share Advisors LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 11,146 shares of ABCL stock, worth $62,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,146
Previous 13,443
17.09%
Holding current value
$62,640
Previous $29,000
31.03%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ABCL
# of Institutions
149Shares Held
114MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$155 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$75.1 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$58.2 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$47.6 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$25.6 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.6B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...